Alzheimer's Disease is the number three cause of death in Orange County. The last 20+ years of Alzheimer's research evaluating hundreds of therapies have not yielded any significant breakthrough in a medication that can modify the trajectory of this condition.
This year is different.
Join Dr. Dung Trinh, Internal Medicine physician with Greater Newport Physicians, as he discusses the latest news on the FDA's decision for accelerated approval of Lecanemab, an anti-Amyloid Alzheimer's medication that has the potential to change the trajectory of Alzheimer's disease.
Dr. Trinh will also be discussing the new strategies for screening, diagnosis and reducing Alzheimer's risk factors through life-style modification and nutrition.
On-site computerized memory testing will be offered.
Light refreshments will be served.
Registration is required.